Physiotherapy, and speech and language therapy intervention for patients with refractory chronic cough: A multicentre randomised control trial

Thorax

Volumn 72, Issue 2, 2017, Pages 129-136

  Chamberlain Mitchell, Sarah A F ^a,b   Garrod, Rachel ^a   Clark, Lynne ^c   Douiri, Abdel ^a   Parker, Sean M ^d   Ellis, Jenny ^d   Fowler, Stephen J ^e   Ludlow, Siobhan ^f   Hull, James H ^g   Chung, Kian Fan ^g   Lee, Kai K ^a   Bellas, H ^h   Pandyan, Anand ^b   Birring, Surinder S ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b KEELE UNIVERSITY   (United Kingdom)

^c KING S COLLEGE HOSPITAL   (United Kingdom)

^d NORTH TYNESIDE GENERAL HOSPITAL   (United Kingdom)

^e UNIVERSITY OF MANCHESTER   (United Kingdom)

^f LEIGHTON HOSPITAL   (United Kingdom)

^g ROYAL BROMPTON AND HAREFIELD NHS FOUNDATION TRUST   (United Kingdom)

^h UNIVERSITY COLLEGE LONDON HOSPITALS   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CAPSAICIN;

ADULT; AGED; ARTICLE; BREATHING EXERCISE; CHRONIC COUGH; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HEALTHY LIFESTYLE; HUMAN; HYDRATION; INTENTION TO TREAT ANALYSIS; INTERVENTION STUDY; LARYNGEAL HYGIENE; LEICESTER COUGH QUESTIONNAIRE; MALE; MULTICENTER STUDY; PERSONAL HYGIENE; PHYSIOTHERAPY; POPULATION RESEARCH; PSYCHOEDUCATION; QUALITY OF LIFE; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; REFRACTORY CHRONIC COUGH; SPEECH AND LANGUAGE REHABILITATION; CHRONIC DISEASE; CLINICAL TRIAL; COUGH; COUNSELING; LANGUAGE THERAPY; MIDDLE AGED; SINGLE BLIND PROCEDURE; SPEECH THERAPY; TREATMENT OUTCOME;

AGED; CHRONIC DISEASE; COUGH; COUNSELING; FEMALE; HUMANS; LANGUAGE THERAPY; MALE; MIDDLE AGED; PHYSICAL THERAPY MODALITIES; QUALITY OF LIFE; SINGLE-BLIND METHOD; SPEECH THERAPY; TREATMENT OUTCOME;

EID: 85011277028     PISSN: 00406376     EISSN: 14683296     Source Type: Journal    
DOI: 10.1136/thoraxjnl-2016-208843     Document Type: Article

References (47)

1. Morice AH, McGarvey L, Pavord I, On behalf of the British Thoracic Society Cough Guideline Group. Recommendations for the management of cough in adults. Thorax 2006;61(Suppl 1):1-24.
2. Ford AC, Forman D, Moayyedi P, et al. Cough in the community: a cross sectional survey and the relationship to gastrointestinal symptoms. Thorax 2006;61:975-9.
3. Morice A. Chronic cough: epidemiology. Chron Respir Dis 2008;5:43-7.
4. Morice AH, Fontana GA, Sovijarvi AR, et al. The diagnosis and management of chronic cough. Eur Respir J 2004;24:481-92.
5. Irwin R, Baumann MH, Bolser DC, et al. Diagnosis and management of cough executive summary: ACCP evidence-based clinical practice guidelines. Chest 2006;129(1 Suppl):1S-23S.
6. Haque RA, Usmani OS, Barnes PJ. Chronic idiopathic cough: a discrete clinical entity Chest 2005;127:1710-13.
7. Brignall K, Jayaraman B, Birring SS. Quality of life and psychosocial aspects of cough. Lung 2008;186(Suppl 1):S55-8.
8. Birring SS, Prudon B, Carr AJ, et al. Development of a symptom specific health status measure for patients with chronic cough: Leicester Cough Questionnaire (LCQ). Thorax 2003;58:339-43.
9. French CL, Irwin RS, Curley FJ, et al. Impact of chronic cough on quality of life. Arch Intern Med 1998;158:1657-61.
10. Chung KF. Clinical cough VI: the need for new therapies for cough: disease-specific and symptom-related antitussives. Handb Exp Pharmacol 2009;187:343-68.
11. Belvisi MG, Geppetti P. Cough. 7: Current and future drugs for the treatment of chronic cough. Thorax 2004;59:438-40.
12. Ryan NM, Birring SS, Gibson PG. Gabapentin for refractory chronic cough: a randomised, double-blind, placebo-controlled trial. Lancet 2012;380:1583-9.
13. Abdulqawi R, Dockry R, Holt K, et al. P2X3 receptor antagonist (AF-219) in refractory chronic cough: a randomised, double-blind, placebo-controlled phase 2 study. Lancet 2015;385:1198-205.
14. Morice AH, Menon MS, Mulrennan SA, et al. Opiate therapy in chronic cough. Am J Respir Crit Care Med 2007;175:312-15.
15. Vertigan AE, Kapela SL, Ryan NM, et al. Pregabalin and speech pathology combination therapy for refractory chronic cough: a randomized controlled trial. Chest 2016;149:639-48.
16. Jeyakumar A, Brickman TM, Haben M. Effectiveness of amitriptyline versus cough suppressants in the treatment of chronic cough resulting from postviral vagal neuropathy. Laryngoscope 2006;116:2108-12.
17. Chamberlain S, Birring SS, Garrod R. Nonpharmacological interventions for refractory chronic cough patients: systematic review. Lung 2014;192:75-85.
18. Chamberlain S, Garrod R, Birring SS. Cough suppression therapy: does it work Pulm Pharmacol Ther 2013;26:524-7.
19. Vertigan AE, Theodoros DG, Gibson PG, et al. Efficacy of speech pathology management for chronic cough: a randomised placebo controlled trial of treatment efficacy. Thorax 2006;61:1065-9.
20. Patel AS, Watkin G, Willig B, et al. Improvement in health status following cough-suppression physiotherapy for patients with chronic cough. Chron Respir Dis 2011;8:253-8.
21. Ryan NM, Vertigan AE, Bone S, et al. Cough reflex sensitivity improves with speech language pathology management of refractory chronic cough. Cough 2010;6:5.
22. Ryan NM, Vertigan AE, Gibson PG. Chronic cough and laryngeal dysfunction improve with specific treatment of cough and paradoxical vocal fold movement. Cough 2009;5:4.
23. Vertigan A, Theodoros D, Winkworth A, et al. Chronic cough: a tutorial for speech language pathologists. J Med Speech Lang Pathol 2007;15:189-206.
24. Department of Health. Start active, stay active. UK: Department of Health, 2011.
25. NHS. Eight tips for healthy eating. 2013. http://www.nhs.uk/Livewell/Goodfood/Pages/eight-tips-healthy-eating.aspx (accessed 05/10/2015).
26. NHS. Relaxation tips to relieve stress. 2013. http://www.nhs.uk/Conditions/stress-anxiety-depression/Pages/ways-relieve-stress.aspx (accessed 05/10/2015).
27. Raj AA, Pavord DI, Birring SS. Clinical cough IV: what is the minimal important difference for the Leicester Cough Questionnaire Handb Exp Pharmacol 2009; (187):311-20.
28. Birring SS, Fleming T, Matos S, et al. The Leicester Cough Monitor: preliminary validation of an automated cough detection system in chronic cough. Eur Respir J 2008;31:1013-18.
29. Yousaf N, Monteiro W, Parker D, et al. Long-term low-dose erythromycin in patients with unexplained chronic cough: a double-blind placebo controlled trial. Thorax 2010;65:1107-10.
30. Morice AH, Fontana GA, Belvisi MG, et al. ERS guidelines on the assessment of cough. Eur Respir J 2007;29:1256-76.
31. Boulet LP, Coeytaux RR, McCrory DC, et al. Tools for assessing outcomes in studies of chronic cough: CHEST guideline and expert panel report. Chest 2015;147:804-14.
32. Carding PN, Horsley IA. An evaluation study of voice therapy in non-organic dysphonia. Eur J Disord Commun 1992;27:137-58.
33. Vertigan AE, Theodoros DG, Winkworth AL, et al. Perceptual voice characteristics in chronic cough and paradoxical vocal fold movement. Folia Phoniatr Logop 2007;59:256-67.
34. Brazier JE, Harper R, Jones NM, et al. Validating the SF-36 health survey questionnaire: new outcome measure for primary care. BMJ 1992;305:160-4.
35. Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand 1983;67:361-70.
36. Lacson E, Xu J, Lin SF, et al. A comparison of SF-36 and SF-12 composite scores and subsequent hospitalization and mortality risks in long-term dialysis patients. Clin J Am Soc Nephrol 2010;5:252-60.
37. Birring SS, Pavord ID. Assessment of gender differences in health status with the Leicester Cough Questionnaire (LCQ). Thorax 2009;64:1008-9.
38. Little RJ, D'Agostino R, Cohen ML, et al. The prevention and treatment of missing data in clinical trials. N Engl J Med 2012;367:1355-60.
39. Spinou A, Birring SS. An update on measurement and monitoring of cough: what are the important study endpoints J Thorac Dis 2014;6(Suppl 7):S728-34.
40. Birring SS, Murphy AC, Scullion JE, et al. Idiopathic chronic cough and organ-specific autoimmune diseases: a case-control study. Respir Med 2004;98:242-6.
41. Lee KK, Savani A, Matos S, et al. Four-hour cough frequency monitoring in chronic cough. Chest 2012;142:1237-43.
42. Lee KK, Matos S, Evans DH, et al. A longitudinal assessment of acute cough. Am J Respir Crit Care Med 2013;187:991-7.
43. Yousaf N, Monteiro W, Matos S, et al. Cough frequency in health and disease. Eur Respir J 2013;41:241-3.
44. Webb AL, Carding PN, Deary IJ, et al. Optimising outcome assessment of voice interventions, I: reliability and validity of three self-reported scales. J Laryngol Oto 2007;121:763-7.
45. Jacobson BH, Johnson A, Grywalski C, et al. The voice handicap index (VHI): development and validation. Am J Speech Lang Pathol 1997;6:66-70.
46. Deary IJ, Wilson JA, Carding PN, et al. VoiSS: a patient-derived Voice Symptom Scale. J PsychoSom Res 2003;54:483-9.
47. Birring SS. Controversies in the evaluation and management of chronic cough. Am J Respir Crit Care Med 2011;183:708-15.